The grand expectation of this oral-lyn release was to be non inferiority to injected insulin as measured by HbA1c levels in patients met or exceeded. This primary target of the Phase III Study has not been met. The oral-lyn ruse and marketing ploy rambles on down a path of deception and will soon be taking no prisoners. Bagholders are doomed here. You were and have been warned.
Hey if_biff you genius, these were phase II results for patients with type II diabetes I think. If you look back at previous press releases, Phase III results will not be released until atleast December, how about doing some DD next time?
please don.t cite the recent release of abstract data from European meeting as evidence of phase 3 data...those data have not been released on oral-lyn...again please do not distort and attempt to confuse....it just dose not work !!
"You were and have been warned."
"? Isn't that two ways of same the same brainless thing? lols "
Brainless- Long term bagholders here were warned.
Those soon to become bagholders are being warned.
A Reverse Split is coming.
You have more glycated hemoglobin if you have had high levels of glucose in your blood. In general, the higher your HbA1c, the higher the risk that you will develop problems such as:
* Eye disease
* Heart disease
* Kidney disease
* Nerve damage
This is especially true if your HbA1c remains high for a long period of time.
The closer your HbA1c is to normal, the less risk you have for these complications.
An HbA1c of 6% or less is normal. A HbA1c above 6.5% is a newly recommended criterion for diagnosing diabetes.
If you have diabetes, you should try to keep your HbA1c level at or below 7%.
Abnormal results mean that your blood glucose levels have been above normal over a period of weeks to months. If your HbA1c is above 7%, it means that your diabetes control may not be as good as it should be.
High values mean you are at greater risk of diabetes complications. If you can bring your level down, you decrease your chances of long-term complications.
Oral-lyn best results come in well above 7% levels. Nothing in the abstract alludes to HbA1c news.